148 related articles for article (PubMed ID: 218118)
1. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
Schrör K; Rösen P
Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin increases cAMP in coronary arteries.
Kukovetz WR; Holzmann S; Wurm A; Pöch G
J Cyclic Nucleotide Res; 1979 Dec; 5(6):469-76. PubMed ID: 231612
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of coronary arterial relaxation by prostacyclin.
Holzmann S; Kukovetz WR; Schmidt K
J Cyclic Nucleotide Res; 1980; 6(6):451-60. PubMed ID: 6163806
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin stimulation of dog arterial cyclic AMP levels.
Miller OV; Aiken JW; Hemker DP; Shebuski RJ; Gorman RR
Prostaglandins; 1979 Dec; 18(6):915-25. PubMed ID: 232764
[TBL] [Abstract][Full Text] [Related]
5. Elevation of cyclic AMP by prostacyclin is accompanied by relaxation of bovine coronary arteries and contraction of rabbit aortic rings.
Vegesna RV; Diamond J
Eur J Pharmacol; 1986 Aug; 128(1-2):25-31. PubMed ID: 3019739
[TBL] [Abstract][Full Text] [Related]
6. PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine.
Dembinska-Kiec A; Rücker W; Schönhöfer PS
Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):107-10. PubMed ID: 91976
[TBL] [Abstract][Full Text] [Related]
7. Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries.
Dembinska-Kiec A; Rücker W; Schönhöfer PS
Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):67-70. PubMed ID: 6154247
[TBL] [Abstract][Full Text] [Related]
8. Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro.
Schrör K; Link HB; Rösen R; Klaus W; Rösen P
Eur J Pharmacol; 1980 Jun; 64(4):341-8. PubMed ID: 6156077
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin (PGI2) mediates hypoxic relaxation of bovine coronary arterial strips.
Roberts AM; Messina EJ; Kaley G
Prostaglandins; 1981 Apr; 21(4):555-69. PubMed ID: 7019974
[TBL] [Abstract][Full Text] [Related]
10. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
[TBL] [Abstract][Full Text] [Related]
12. The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculature.
Schrör K
Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):213-7. PubMed ID: 381947
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig.
Dusting GJ; Moncada S; Vane JR
Eur J Pharmacol; 1977 Oct; 45(3):301-4. PubMed ID: 336382
[TBL] [Abstract][Full Text] [Related]
14. Physiological and biochemical parameters of prostacyclin action on the heart and the coronary vasculature.
Schrör K; Rösen R; Link HB; Rösen P
Adv Prostaglandin Thromboxane Res; 1980; 7():625-30. PubMed ID: 6154408
[No Abstract] [Full Text] [Related]
15. Prostaglandins and cyclic nucleotides: effects of PGI2 and PGE1 on cardiac hemodynamic and coronary arterial and myocardial cyclic nucleotide levels in dogs.
Ito T; Ogawa K; Enomoto I; Hashimoto H; Kai I; Sakai K; Satake T
Jpn Circ J; 1980 Sep; 44(9):755-61. PubMed ID: 6251292
[TBL] [Abstract][Full Text] [Related]
16. Coronary vasodilation: interactions between prostacyclin and adenosine.
Blass KE; Förster W; Zehl U
Br J Pharmacol; 1980 Aug; 69(4):555-9. PubMed ID: 7002243
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin: effects on cyclic AMP in bone cells.
Robin JC; Brown MJ; Weinfeld N; Dziak R
Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):43-9. PubMed ID: 6276954
[TBL] [Abstract][Full Text] [Related]
18. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
Weithmann KU
Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
[TBL] [Abstract][Full Text] [Related]
19. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
